These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 335605)

  • 21. Donor pretreatment on perfused cadaver kidneys: experimental observations.
    Sy G; Taiyebb S; Toledo-Pereyra LH
    Am Surg; 1981 Jul; 47(7):307-8. PubMed ID: 7020513
    [No Abstract]   [Full Text] [Related]  

  • 22. Improved survival after donor pretreatment with anti-lymphoblast globulin (ALG) in perfused kidneys: experimental findings.
    Toledo-Pereyra LH; Taiyebb S; McKenzie GH; Gordon DA; Sy GS
    J Surg Res; 1981 Aug; 31(2):172-7. PubMed ID: 7022024
    [No Abstract]   [Full Text] [Related]  

  • 23. Renal transplantation in the inbred rat. 18. Effect of cyclophosphamide on acute rejection and long survival of recipients.
    Kawabe K; Guttmann RD; Levin B; Merrill JP; Lindquist RR
    Transplantation; 1972 Jan; 13(1):21-6. PubMed ID: 4550343
    [No Abstract]   [Full Text] [Related]  

  • 24. High intravenous doses of methylprednisolone for acute cadaveric renal allograft rejection.
    Mussche MM; Ringoir SM; Lameire NN
    Nephron; 1976; 16(4):287-91. PubMed ID: 765873
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of immunologic donor pretreatment on survival of perfused canine renal allografts.
    Pechan W; Novick AC; Stowe N; Magnusson M; Straffon RA
    Invest Urol; 1980 Jul; 18(1):74-6. PubMed ID: 6997225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oral versus intravenous high-dose steroid treatment of renal allograft rejection. The big shot or not?
    Gray D; Shepherd H; Daar A; Oliver DO; Morris PJ
    Lancet; 1978 Jan; 1(8056):117-8. PubMed ID: 87551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The adverse effect of high-dose steroids on renal autografts and homografts.
    Tremann JA; Agodoa LC; Cooper TP; Striker GE; Marchioro TL
    Surgery; 1976 Apr; 79(4):370-6. PubMed ID: 769217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of cyclophosphamide and enhancing serum to suppress renal allograft rejection in the rat.
    Winearls CG; Fabre JW; Millard PR; Morris PJ
    Transplantation; 1979 Oct; 28(4):271-4. PubMed ID: 388758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Steroid-cyclophosphamide pretreatment of kidney allograft donors. A control study.
    Soulillou JP; Baron D; Rouxel A; Guenel J
    Nephron; 1979; 24(4):193-7. PubMed ID: 386157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosage of corticosteroids in renal allograft rejection.
    Silberman H
    Am J Surg; 1981 Sep; 142(3):413-5. PubMed ID: 7025673
    [No Abstract]   [Full Text] [Related]  

  • 31. Factors influencing outcome of kidney allografts from pretreated cadaveric donors.
    Sterioff S; Zincke H; Waltzer WC; Moore SB; Frohnert PP; Offord KP
    Arch Surg; 1981 Jan; 116(1):73-7. PubMed ID: 7008743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of high-dose intravenous methylprednisolone with low-dose oral prednisolone in acute renal allograft rejection in children.
    Orta-Sibu N; Chantler C; Bewick M; Haycock G
    Br Med J (Clin Res Ed); 1982 Jul; 285(6337):258-60. PubMed ID: 6807439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High- versus low-dose methylprednisolone for acute rejection episodes in renal transplantation.
    Park GD; Bartucci M; Smith MC
    Nephron; 1984; 36(2):80-3. PubMed ID: 6363949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretreatment of cadaver donors with cyclophosphamide and methylprednisolone: effect on renal transplant outcome.
    Corry RJ; Patel NP; West JC; Schanbacher BA
    Transplant Proc; 1980 Jun; 12(2):348-51. PubMed ID: 6994305
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunosuppression and rehabilitation following cadaveric renal transplantation. New developments.
    Guttmann RD; Beaudoin JG; Gonda A; Gorman P
    Urology; 1973 Feb; 1(2):102-7. PubMed ID: 4589225
    [No Abstract]   [Full Text] [Related]  

  • 36. Passive enhancement of canine renal allografts with polyspecific F(ab')2 fragments.
    Wren SF; Martins AC; Von Haefen U; Busch GJ; Katske GE; Koppenheffer TL; Shaipanich T; Wilson RE
    Surgery; 1974 Jul; 76(1):112-20. PubMed ID: 4135410
    [No Abstract]   [Full Text] [Related]  

  • 37. Donor pretreatment with cyclophosphamide and methylprednisolone.
    Brom HL; van Breda Vriesman PJ
    Transplantation; 1983 Jul; 36(1):106-7. PubMed ID: 6408773
    [No Abstract]   [Full Text] [Related]  

  • 38. Prolongation of canine renal allografts in the immunosuppressed host by donor pretreatment with cytolytic agents.
    McCabe R; Swistel A; Lorieo D; Fitzpatrick HF
    Transplant Proc; 1980 Jun; 12(2):355-7. PubMed ID: 6156529
    [No Abstract]   [Full Text] [Related]  

  • 39. Mode of administration of steroids in treatment of renal-allograft rejection.
    Touraine JL; Traeger J
    Lancet; 1978 Mar; 1(8064):607. PubMed ID: 76143
    [No Abstract]   [Full Text] [Related]  

  • 40. Intravenous methylprednisolone at the time of renal transplantation.
    Heaton A; Wilkinson R; Elliott RW; Ward MK; Taylor RM; Proud G
    Proc Eur Dial Transplant Assoc; 1983; 19():482-7. PubMed ID: 6348749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.